Jennifer J. Rhodes
2023
In 2023, Jennifer J. Rhodes earned a total compensation of $1.4M as former Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate Secretary at Elicio Therapeutics, a 77% increase compared to previous year.
Compensation breakdown
| Bonus | $440,840 |
|---|---|
| Salary | $222,257 |
| Other | $702,762 |
| Total | $1,365,859 |
Rhodes received $702.8K in other compensation, accounting for 51% of the total pay in 2023.
Rhodes also received $440.8K in bonus and $222.3K in salary.
Rankings
In 2023, Jennifer J. Rhodes' compensation ranked 865th out of 2,918 executives tracked by ExecPay. In other words, Rhodes earned more than 70.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 865 out of 2,918 | 70th |
Division Manufacturing | 510 out of 1,608 | 68th |
Major group Chemicals And Allied Products | 348 out of 901 | 61st |
Industry group Drugs | 338 out of 864 | 61st |
Industry Pharmaceutical Preparations | 229 out of 622 | 63rd |
Source: SEC filing on September 27, 2024.
Rhodes' colleagues
We found four more compensation records of executives who worked with Jennifer J. Rhodes at Elicio Therapeutics in 2023.